A prospective, open label, single arm study to evaluate the safety and efficacy of an olmesartan medoxomil based treatment regimen in type II diabetic patients with hypertension.

Trial Profile

A prospective, open label, single arm study to evaluate the safety and efficacy of an olmesartan medoxomil based treatment regimen in type II diabetic patients with hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Aug 2017

At a glance

  • Drugs Olmesartan medoxomil (Primary) ; Hydrochlorothiazide
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms BENIFICIARY
  • Sponsors Daiichi Sankyo Inc
  • Most Recent Events

    • 22 Sep 2009 Planned number of patients changed from 200 to 192 as reported by ClinicalTrials.gov.
    • 11 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 02 Oct 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top